PRAC: Agendas, minutes and highlights

31 March 2023

Minutes of the PRAC meeting 4-7 July 2022

31 March 2023

PRIME: priority medicines

31 March 2023

Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Neuroblastoma, Date of authorisation: 08/05/2017, Revision: 14, Status: Authorised

31 March 2023

European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, Hybrid, from 03/03/2023 to 03/03/2023

31 March 2023

Human medicines European public assessment report (EPAR): Aldurazyme, laronidase, Mucopolysaccharidosis I, Date of authorisation: 09/06/2003, Revision: 24, Status: Authorised

31 March 2023

Herbal medicinal product: Fragariae folium, Fragariae folium, C: ongoing call for scientific data

31 March 2023

Call for scientific data for the periodic review of the monograph on Fragariae folium - Revision 1

31 March 2023

Guideline on Quality Aspects of Pharmaceutical Veterinary Medicines for administration via drinking water - Draft Annex on compatibility studies between veterinary medicinal products and biocidal products

31 March 2023

CTIS newsflash – 31 March 2023

31 March 2023